DB
OGN icon

Dmitry Balyasny’s Organon & Co OGN Stock Holding History

Dmitry Balyasny’s Portfolio OGN Stock Details OGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.12M Buy
+600,000
New +$7.17M 0.01% 1148

Other funds holding OGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $62.7B AUM 29.77% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return

Dmitry Balyasny's OGN Position: Q2 2026 in Review

Dmitry Balyasny increased its Organon & Co (OGN) stake by 908% in Q2 2026, buying an estimated $23.7M and bringing the position to 2,196,642 shares worth $29.7M. The position accounts for 0.04% of the portfolio, ranked #552.

Dmitry Balyasny first reported a position in OGN in Q2 2021 and has held it in 17 quarters since. The position peaked at $53.7M in Q1 2023. 627 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

  • Dmitry Balyasny held 2,196,642 shares of Organon & Co worth $29.7M as of Q2 2026.
  • Dmitry Balyasny bought 1,978,742 Organon & Co shares in Q2 2026, an estimated $23.7M.
  • Organon & Co made up 0.04% of Dmitry Balyasny's portfolio in Q2 2026, its #552 holding.
  • Dmitry Balyasny first reported a position in Organon & Co in Q2 2021 and has held it in 17 quarters since.
  • Dmitry Balyasny's Organon & Co position peaked at $53.7M in Q1 2023.
  • 627 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.